Ashay Dilip Bhatwadekar (Ashay Bhatwadekar, Ashay D Bhatwadekar)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Heat Shock Protein

Diabetic Retinopathy

Genome Wide Association

General Practice

Top Venues

Expert opinion on biological therapy

Expert opinion on investigational drugs

Clinical interventions in aging

This page only lists publications with an associated author ORCID identifier.

Publications

Aumer Shughoury, Ashay Dilip Bhatwadekar, Denis Jusufbegovic, Amir Hajrasouliha, Thomas A Ciulla
The evolving therapeutic landscape of diabetic retinopathy. Expert opinion on biological therapy (2023)
Deepa Mathew, Qianyi Luo, Ashay Dilip Bhatwadekar
Circadian rhythm disruption results in visual dysfunction. FASEB bioAdvances 4 (6) (2022)
Janvi Patel, Jasmine D Gonzalvo, George Joseph Eckert, Andrew N Schmelz, Ashay Dilip Bhatwadekar
Pharmacist-Managed Diabetic Retinopathy in Hispanic/LatinX Population. Journal of pharmacy practice (2022)
Qianyi Luo, Sameer P Leley, Erika Bello, Hurshdeep Dhami, Deepa Mathew, Ashay Dilip Bhatwadekar
Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes. BMJ open diabetes research & care 10 (3) (2022)
Sameer P Leley, Thomas A Ciulla, Ashay Dilip Bhatwadekar
Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment. Clinical interventions in aging 16 (2021)
Ashay Dilip Bhatwadekar, Aumer Shughoury, Ameya Belamkar, Thomas A Ciulla
Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World. Genes 12 (8) (2021)
Ashay Dilip Bhatwadekar, Varun Rameswara
Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs. Expert opinion on investigational drugs 29 (12) (2020)
Michael C Gemayel, Ashay Dilip Bhatwadekar, Thomas A Ciulla
RNA therapeutics for retinal diseases. Expert opinion on biological therapy 21 (5) (2020)
Ashay Dilip Bhatwadekar, Viral Kansara, Qianyi Luo, Thomas A Ciulla
Anti-integrin therapy for retinovascular diseases. Expert opinion on investigational drugs 29 (9) (2020)
Kayla Thompson, Jonathan Chen, Qianyi Luo, Yucheng Xiao, Theodore R Cummins, Ashay Dilip Bhatwadekar
Advanced glycation end (AGE) product modification of laminin downregulates Kir4.1 in retinal Müller cells. PloS one 13 (2) (2018)
Eleni Beli, Yuanqing Yan, Leni Moldovan, Cristiano P Vieira, Ruli Gao, Yaqian Duan, Ram Prasad, Ashay Dilip Bhatwadekar, Fletcher A White, Steven D Townsend, Luisa Chan, Caitlin N Ryan, Daniel Morton, Emil G Moldovan, Fang-I Chu, Gavin Y Oudit, Hartmut Derendorf, Luciano Adorini, Xiaoxin X Wang, Carmella Evans-Molina, Raghavendra G Mirmira, Michael E Boulton, Mervin C Yoder, Qiuhong Li, Moshe Levi, Julia V Busik, Maria B Grant
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice. Diabetes 67 (9) (2018)
Zachary A Weber, Palakpreet Kaur, Amrita Hundal, Somnooma H Ibriga, Ashay Dilip Bhatwadekar
Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures. Pharmacy practice 17 (1) (2018)